With the clearing out of Artimist and ability to focus on some...

With the clearing out of Artimist and ability to focus on some of the key other drug assets, perhaps this is a great opportunity to reflect on the future direction of SUDA.

We know that there is going to be some serious correction in value over the next few days with the MC likely to fall 10-20% lower.

However, the focus on the remaining assets, some of which are quite brilliant, could lead us to glory over the next few months and years.

Let's put the SUDA stock in the bottom drawer and hang on to them for the next few years and revisit them then.